ACME Capital — 2024 Investments
5 investments dated 2024 · listed companies and verified rows first · show all
Decagon provides AI agents that enable businesses to deliver personalized customer experiences at scale.
AI & Machine LearningEnterprise SoftwareSaaSSan Francisco, US
Jesse Zhang(Executive Officer, Director)inIvan Zhou(Director)in
BoardAaref Hilaly(Director)inAshwin Sreenivas(Director)in
Co-investorsA*AccelAndreessen HorowitzAtacama VenturesAudaciousBain Capital Ventures+8 more
Invert provides infrastructure and intelligence software that connects bioprocess equipment and data sources for pharmaceutical and biologics companies, enabling faster process development and manufacturing through integrated data platforms and digital twin capabilities.
AI & Machine LearningBiotechData & InfrastructureEnterprise SoftwareHealthtechSan Francisco, US
Martin T. Permin(Founder)inHolger Thorup(Founder)inSam Cates(Director)
BoardChristian Tang-Jespersen(Director)in
Co-investorsCathexis VenturesGiant Ventures Global LlpY CombinatorTechNexus Venture Collaborative
Pier builds financial access tools for innovators and entrepreneurs.
AI & Machine LearningEnterprise SoftwareFintechSaaSSan Francisco, US
Jessica Zhang(Founder)inAlex Hegevall Clarke(Founder)
Co-investorsHorizonNeer Venture PartnersY CombinatorLiquid Ventures
Pier is a digital insurance company offering auto insurance and mobile phone insurance (against theft and robbery) to consumers in Brazil, managed through an app with no waiting period, deductible, or lock-in contracts.
ConsumerFintechInsurTech
Co-investorsAirborne VenturesMONASHEESNorte VenturesLiquid VenturesY Combinator
Reshape provides an AI-driven operating system that automates microbiology data capture and analysis for research laboratories.
AI & Machine LearningBiotechDeep TechHealthtechRoboticsCopenhagen, DK
Carl-Emil Grøn Fuglesang(Founder)Magnus Nyborg Madsen(Founder)inDaniel Storgaard(Founder)in
Co-investorsAstanor VenturesFundersClubY CombinatorACMER7 Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.